Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |